Variant · Deletion
GATB NM_004564.3(GATB):c.1198-6del
CI-VAR-00199819Explore in graph →NM_004564.3:c.1198-6delClinVar 1252303 rs11292952
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-06
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260908-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 1252303 | Benign | criteria provided, multiple submitters, no conflicts | 2 | Combined oxidative phosphorylation deficiency 41; GATB-related disorder; Hepatocellular carcinoma; Lymphoma; Nonpapillary renal cell carcinoma; Chronic lymphocytic leukemia/small lymphocytic lymphoma | germline | 5 | Feb 16, 2025 | clinvar |